Malignancy, infectious disease
Conditions
Interventions
None listed
Sponsors
Toppan printing Co., LTD.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Tumor marker (CEA, CA19-9, AFP) positive case Cytomegalovirus antigenemia positive case
Exclusion criteria
Exclusion criteria: Refusal to participate in this clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Accuracy | — |
Secondary
| Measure | Time frame |
|---|---|
| rapidity | — |
Countries
Japan
Contacts
Public ContactSachiko Matsuda
Keio University School of Medicine Department of Surgery
Outcome results
None listed